We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Protedyne Completes Installation of BioCube System at Correlagen
News

Protedyne Completes Installation of BioCube System at Correlagen

Protedyne Completes Installation of BioCube System at Correlagen
News

Protedyne Completes Installation of BioCube System at Correlagen

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Protedyne Completes Installation of BioCube System at Correlagen"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Protedyne Corporation has announced it has completed the installation and site acceptance of its BioCube System LX 2000 at Correlagen Diagnostics

Correlagen selected the BioCube System to automate their Genes That Matter™ gene testing service. The BioCube System will optimize their clinical workflow for throughput, analytical procedures, and data handling needs. 

The BioCube System will integrate PCR setup, PCR cleanup, sequencing reaction setup, and sequencing reaction cleanup in a continuous process.   

"We are pleased to have provided Correlagen with technology that addresses their need to automate complex testing protocols as well as the throughput requirements for their molecular diagnostic test menu," said Fran Tutttle, President and CEO of Protedyne. "We look forward to being a part of their future success."

"Protedyne’s BioCube System is proving to be an excellent platform for implementing Correlagen’s software and gene sequencing methods," said David Margulies, M.D., CEO of Correlagen.

"Our throughput, quality, and costs are unmatched, and the BioCube System is a major component of our success."

"Correlagen’s alliance program with academic and pharmaceutical collaborators is based in large part on the capabilities we have created on this automated platform," added Joyce Samet, Senior Vice President. "Correlagen looks forward to extending our relationship with Protedyne."

Advertisement